Lipid lowering therapy: implications of recent clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid lowering therapy: implications of recent clinical trials

Published:2024-02 Issue:2 Volume:20 Page:89-98
ISSN:1479-6678
Container-title:Future Cardiology
language:en
Short-container-title:Future Cardiol.

Author:

Backes James M¹,Hilleman Daniel E²

Affiliation:

1. Clinical & Medical Center Affairs, University of Kansas Medical Center, KU School of Pharmacy, Department of Pharmacy Practice, 2010 Becker Drive, Lawrence, KS 66047, USA

2. Creighton University School of Pharmacy & Health Professions, 2500 California Plaza, Omaha, NE68178, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fca-2023-0132

Reference35 articles.

1. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

2. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential

3. Bempedoic Acid (ETC-1002)

4. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

5. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety assessment of traditional Chinese patent medicine for dyslipidemia: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis;Cardiovascular Diagnosis and Therapy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP